COMP <GO>
CHE vs UNH // FREE CASH FLOW YIELD
Chemed Corp (NYSE) VS. UnitedHealth Group Incorporated (NYSE) • 15-METRIC TALLY: CHE 6
— UNH 8
▲ FREE CASH FLOW YIELD LEADER: UNH
LAST: $534.72 (-1.33%) • MKT CAP: $7.08B
fcf-yield
4.60%
LAST: $406.97 (-0.96%) • MKT CAP: $364.66B
fcf-yield
6.48%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CHE VS. UNH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CHE | UNH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 32.50% | 88.57% | -56.07 | UNH | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 23.40% | 11.47% | +11.93 | CHE | /roic <GO> |
| EV/EBITDA & P/E Valuation | 18.5x | 16.4x | +2.05 | UNH | /valuation <GO> |
| Free Cash Flow Yield ACTIVE | 4.60% | 6.48% | -1.88 | UNH | /fcf-yield <GO> |
| Operating Margin | 13.40% | 4.82% | +8.58 | CHE | /operating-margins <GO> |
| Net Profit Margin | 0.00% | 3.14% | -3.14 | UNH | /net-margins <GO> |
| Revenue Growth (YoY) | 65.30% | 6.46% | +58.84 | CHE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.45% | 2.28% | -1.83 | UNH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 12.68 | 3.12 | +9.56 | CHE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 7/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.20% | 6.74% | +0.46 | UNH | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 61.8 | 56.0 | +5.74 | CHE | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.08 | 0.33 | +0.75 | CHE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 140.0x | 17.1x | +122.91 | UNH | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $7.08B | $364.66B | -$357.58B | UNH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CHE REV | UNH REV | CHE GROSS % | UNH GROSS % | CHE FCF | UNH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $2.53B | $447.57B | 32.5% | 88.7% | $325.5M | $16.07B |
| FY 2024 | $1.53B | $400.28B | -3.0% | 88.3% | $368.0M | $20.70B |
| FY 2023 | $1.32B | $371.62B | 44.0% | 89.6% | $271.1M | $25.68B |
| FY 2022 | — | $324.16B | — | 89.6% | — | $23.40B |
| FY 2021 | — | $287.60B | — | 89.2% | — | $19.89B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CHE // BETA 1.08
UNH // BETA 0.33